1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Recordati
  6. Company
    REC   IT0003828271

RECORDATI

(REC)
  Report
Delayed Borsa Italiana  -  11:35 2022-06-24 am EDT
41.86 EUR   +7.64%
06/20RECORDATI : Share buy-back program to service the stock option plans
PU
06/14RECORDATI : Ultima presentazione del gruppo
PU
06/14RECORDATI : Latest Company presentation
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Recordati specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical and OTC products (75.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;

- medicines for rare diseases (24.3%).

Net sales are distributed geographically as follows: Italy (16.8%), Europe (59.7%), America (14%), Asia and Oceania (6.3%) and Africa (3.2%).

Number of employees : 4 303 people.
Sales per Business
20202021Delta
Specialty & Primary Care1 129.4378%1 196.2275.7% +5.91%
Orphan Drugs319.4422%383.8524.3% +20.16%
EUR in Million
Sales per region
20202021Delta
Europe857.4259.2%942.8959.7% +9.97%
Italy274.5919%265.3616.8% -3.36%
America169.3711.7%221.7614% +30.94%
Australasia95.106.6%99.536.3% +4.66%
Africa52.393.6%50.523.2% -3.57%
EUR in Million
Managers
Name Title Age Since
Robert Koremans Chief Executive Officer 59 2021
Luigi La Corte Group Chief Financial Officer 52 2019
Raffaele Sabia Senior VP-Pharmaceutical Research & Development - -
Giovanni Minora Head-Group Audit & Compliance - 2007
Federica de Medici Director-Investor Relations & Communications 49 2020
Cédric Ripert Vice President-Pharmaceuticals International Sales - 2017
Fritz Squindo Head-Management Accounting Department 66 1992
Witold Urban VP-Central & Eastern Europe Region - -
Gabriele Finzi Vice President-Corporate Development & Licensing - 2019
Roberto Teruzzi Executive VP-Group Industrial Operations - 2015
Members of the board
Name Title Age Since
Andrea Recordati Chairman 50 2021
Michaela Castelli Lead Independent Non-Executive Director 51 2014
Joanna Susan Le Couilliard Independent Non-Executive Director 57 -
Piergiorgio Peluso Independent Non-Executive Director 54 2020
Elisa Corghi Independent Director 49 -
Fritz Squindo Head-Management Accounting Department 66 1992
Giampiero Mazza Executive Director 53 2019
Cathrin Petty Executive Director 49 -
Guido Guidi, Dr. Vice Chairman 69 -
Giorgio de Palma Director 47 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 209,125,156 97,218,698 46.5% 3,537,802 1.7% 46.5%
Shareholders
NameEquities%
FIMEI Finanziaria Industriale Mobiliare ed Immobiliare SpA 108,368,721 51.8%
Mawer Investment Management Ltd. 10,588,200 5.06%
Fidelity Management & Research Co. LLC 6,290,484 3.01%
Recordati Industria Chimica e Farmaceutica S.p.A. 3,777,524 1.81%
The Vanguard Group, Inc. 2,633,407 1.26%
Welch Capital Partners LLC 2,485,272 1.19%
BlackRock Fund Advisors 2,343,666 1.12%
Norges Bank Investment Management 1,749,557 0.84%
State Street Global Advisors Ltd. 1,593,541 0.76%
William Blair Investment Management LLC 1,319,242 0.63%
Holdings
NameEquities%Valuation
RECORDATI (REC) 3,777,524 1.81% 168,665,313 USD
PURETECH HEALTH PLC (PRTC) 9,544,140 3.31% 21,771,520 USD
ERYTECH PHARMA S.A. (ERYP) 431,034 1.39% 529,159 USD
Markets and indexes
- Euronext Milan
- FTSE MIB / MIB ESG, PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  REC:IM
- Reuters Code :  RECI.MI
- Datastream Code :  
Company contact information
Recordati
Via Matteo Civitali 1
IT-20148 Milano, Lombardia

Phone : +39 (0)2 48 78 71
Fax : +39 (0)2 40 073 747
web site : https://www.recordati.it
Brand Portfolio
In partnership withAllbrands.markets
More brands of Recordati
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
RECORDATI-25.91%9 078
JOHNSON & JOHNSON5.02%479 678
ELI LILLY AND COMPANY13.21%293 110
PFIZER, INC.-15.17%289 466
ROCHE HOLDING AG-15.91%272 090
ABBVIE INC.12.51%269 202
NOVO NORDISK A/S6.98%253 053
MERCK & CO., INC.21.52%235 508
ASTRAZENECA PLC24.31%205 217
NOVARTIS AG0.40%183 371
BRISTOL-MYERS SQUIBB COMPANY24.60%168 111
SANOFI13.52%132 461
AMGEN INC.9.07%131 077
GSK PLC9.17%109 224
BAYER AG22.96%59 888
DAIICHI SANKYO CO., LTD.13.23%46 990
CHUGAI PHARMACEUTICAL CO., LTD-4.42%43 454
TAKEDA PHARMACEUTICAL COMPANY LIMITED18.17%42 353
JIANGSU HENGRUI MEDICINE CO., LTD.-33.90%31 965
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-21.70%30 872
ASTELLAS PHARMA INC.16.44%29 034